> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Budget Compromise Gives FDA $160 Million Boost
- URL: https://www.fdaweb.com/budget-compromise-gives-fda-160-million-boost/
- Published: 2024-03-05T12:00:00.000Z
- Updated: 2026-09-14T14:24:30.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156489

Senate and House appropriators have released a joint [spending bill agreement](https://docs.house.gov/billsthisweek/20240304/HMS31169.PDF?ref=fdaweb.com) for fiscal year 2024 that would provide FDA with a $160 million (2.4%) budget boost over last year. The bill proposes $6.7 billion for the agency, which includes $3.5 billion in discretionary spending and $3.2 billion in user fees, but it falls significantly short of the funding sought by the Biden Administration almost a year ago. The funding bill will need to be enacted by 3/8 to avoid an agency partial shutdown, or another stopgap measure would have to be signed to allow more time and avoid any government disruption.

Under the Biden budget proposed in March ([see earlier story](http://fdaweb.com/login.php?sa=v&aid=D5153943&cate=&stid=%241%24i1%2F.Da4.%248%2Fb3G7XETZqtkRKdyO7he.&ref=fdaweb.com)), the agency was seeking a $372 million (10%) boost above current spending levels and a $150 million increase in user fees. The total FDA funding being proposed was $7.2 billion — $500 million less than the proposed budget agreement.

A Senate Appropriations Committee [summary](https://www.appropriations.senate.gov/imo/media/doc/fy24%5Fag-fda%5Fbill%5Fsummary.pdf?ref=fdaweb.com) of the bill says the legislation would provide “$7 million to conduct oversight of cosmetics for the first time ever and $1.5 million to reduce animal testing through alternative methods. It also includes $50 million for the 21st Century Cures Act.”